ADIM
ALEC icon

Alpha DNA Investment Management’s Alector ALEC Stock Holding History

Alpha DNA Investment Management’s Portfolio ALEC Stock Details ALEC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-66,852
Closed -$1.38M – 116
2021
Q4 		$1.38M Buy
+66,852
New +$1.51M 0.87% 94

Other funds holding ALEC

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alpha DNA Investment Management's ALEC Position: Q1 2022 in Review

Alpha DNA Investment Management sold out of Alector (ALEC) in Q1 2022, closing a stake of 66,852 shares — an estimated $1.38M sold.

Alpha DNA Investment Management first reported a position in ALEC in Q4 2021 and held it in 1 quarter. The position peaked at $1.38M in Q4 2021. 166 funds tracked by Wall St. Rank hold ALEC as of Q1 2022.

  • Alpha DNA Investment Management reported no remaining Alector position as of Q1 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 66,852 Alector shares in Q1 2022, an estimated $1.38M.
  • Alpha DNA Investment Management first reported a position in Alector in Q4 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Alector position peaked at $1.38M in Q4 2021.
  • 166 funds tracked by Wall St. Rank held Alector as of Q1 2022.

Based on Alpha DNA Investment Management's 13F filing for Q1 2022, filed 13 May 2022.